Literature DB >> 16237459

Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

Lawryn H Kasper1, Fayçal Boussouar, Kelli Boyd, Wu Xu, Michelle Biesen, Jerold Rehg, Troy A Baudino, John L Cleveland, Paul K Brindle.   

Abstract

The C-terminal activation domain (C-TAD) of the hypoxia-inducible transcription factors HIF-1alpha and HIF-2alpha binds the CH1 domains of the related transcriptional coactivators CREB-binding protein (CBP) and p300, an oxygen-regulated interaction thought to be highly essential for hypoxia-responsive transcription. The role of the CH1 domain in vivo is unknown, however. We created mutant mice bearing deletions in the CH1 domains (DeltaCH1) of CBP and p300 that abrogate their interactions with the C-TAD, revealing that the CH1 domains of CBP and p300 are genetically non-redundant and indispensable for C-TAD transactivation function. Surprisingly, the CH1 domain was only required for an average of approximately 35-50% of global HIF-1-responsive gene expression, whereas another HIF transactivation mechanism that is sensitive to the histone deacetylase inhibitor trichostatin A (TSA(S)) accounts for approximately 70%. Both pathways are required for greater than 90% of the response for some target genes. Our findings suggest that a novel functional interaction between the protein acetylases CBP and p300, and deacetylases, is essential for nearly all HIF-responsive transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237459      PMCID: PMC1283945          DOI: 10.1038/sj.emboj.7600846

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

Review 1.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

Review 2.  Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor.

Authors:  Richard K Bruick
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

3.  Transgenic mice expressing a truncated form of CREB-binding protein (CBP) exhibit deficits in hippocampal synaptic plasticity and memory storage.

Authors:  Marcelo A Wood; Michael P Kaplan; Alice Park; Edward J Blanchard; Ana M M Oliveira; Thomas L Lombardi; Ted Abel
Journal:  Learn Mem       Date:  2005 Mar-Apr       Impact factor: 2.460

4.  c-Jun and the dominant-negative mutant, TAM67, induce vimentin gene expression by interacting with the activator Sp1.

Authors:  Yongzhong Wu; Xueping Zhang; Zendra E Zehner
Journal:  Oncogene       Date:  2003-12-04       Impact factor: 9.867

Review 5.  HIF-1 and hypoxic response: the plot thickens.

Authors:  Lorenz Poellinger; Randall S Johnson
Journal:  Curr Opin Genet Dev       Date:  2004-02       Impact factor: 5.578

6.  Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein.

Authors:  Xiao Yan Zhou; Nobuyuki Shibusawa; Karuna Naik; Delia Porras; Karla Temple; Hesheng Ou; Kelly Kaihara; Michael W Roe; Matthew J Brady; Fredric E Wondisford
Journal:  Nat Med       Date:  2004-05-16       Impact factor: 53.440

7.  CBP histone acetyltransferase activity is a critical component of memory consolidation.

Authors:  Edward Korzus; Michael G Rosenfeld; Mark Mayford
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

8.  Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

Authors:  Juan M Alarcón; Gaël Malleret; Khalid Touzani; Svetlana Vronskaya; Shunsuke Ishii; Eric R Kandel; Angel Barco
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

9.  Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency.

Authors:  Ningling Kang-Decker; Caili Tong; Fayçal Boussouar; Darren J Baker; Wu Xu; Alexey A Leontovich; William R Taylor; Paul K Brindle; Jan M A van Deursen
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

10.  Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300.

Authors:  Cristiano Simone; Peter Stiegler; Sonia-Vanina Forcales; Luigi Bagella; Antonio De Luca; Vittorio Sartorelli; Antonio Giordano; Pier Lorenzo Puri
Journal:  Oncogene       Date:  2004-03-18       Impact factor: 9.867

View more
  79 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

3.  Cited2 is required for fetal lung maturation.

Authors:  Bing Xu; Xiaoling Qu; Shi Gu; Yong-Qiu Doughman; Michiko Watanabe; Sally L Dunwoodie; Yu-Chung Yang
Journal:  Dev Biol       Date:  2008-02-26       Impact factor: 3.582

4.  Systematic identification of gene activities promoting hypoxic death.

Authors:  Meghann E Mabon; Xianrong Mao; York Jiao; Barbara A Scott; C Michael Crowder
Journal:  Genetics       Date:  2008-12-01       Impact factor: 4.562

Review 5.  Mitophagy in tumorigenesis and metastasis.

Authors:  Logan P Poole; Kay F Macleod
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 6.  The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.

Authors:  Jianfei Qi; Maurizio Pellecchia; Ze'ev A Ronai
Journal:  Oncotarget       Date:  2010-09

Review 7.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

8.  Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.

Authors:  T Cherry; S L Longo; Z Tovar-Spinoza; D E Post
Journal:  Gene Ther       Date:  2010-07-22       Impact factor: 5.250

9.  Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.

Authors:  Jorge L Ruas; Utta Berchner-Pfannschmidt; Sohail Malik; Katarina Gradin; Joachim Fandrey; Robert G Roeder; Teresa Pereira; Lorenz Poellinger
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

10.  Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction.

Authors:  Amaya Ortiz-Barahona; Diego Villar; Nuria Pescador; Jorge Amigo; Luis del Peso
Journal:  Nucleic Acids Res       Date:  2010-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.